6.65

0.00% 0.00

After Hours: 6.65

Voyager Therapeutics Inc (VYGR)

Overview News Price History Option Chain Financials Discussions Forecast

Voyager Therapeutics Inc stock is traded at $6.65, with a volume of 478.30K. It is up +0.00% in the last 24 hours and down -5.54% over the past month. Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Previous Close:

$6.65

Open:

$6.54

24h Volume:

478.30K

Relative Volume:

0.90

Market Cap:

$361.83M

Revenue:

$250.01M

Net Income/Loss:

$132.33M

P/E Ratio:

2.9295

EPS:

2.27

Net Cash Flow:

$74.66M

1W Performance:

-5.94%

1M Performance:

-5.54%

6M Performance:

-24.52%

1Y Performance:

-0.89%

1-Day Range:

$6.4009

$6.69

1-Week Range:

$6.4009

$7.23

52-Week Range:

$5.71

$11.72

Voyager Therapeutics Inc Stock (VYGR) Company Profile

Name

Voyager Therapeutics Inc

Sector

Healthcare (1181)

Industry

Biotechnology (671)

Phone

857-259-5340

Address

75 HAYDEN AVENUE, LEXINGTON, MA

Employee

162

Twitter

@VoyagerTx

Next Earnings Date

2024-11-04

Latest SEC Filings

VYGR's Discussions on Twitter

Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-10-23	Initiated	Truist	Buy
Mar-10-23	Initiated	Oppenheimer	Outperform
Oct-07-21	Upgrade	Robert W. Baird	Neutral → Outperform
Feb-26-21	Downgrade	Robert W. Baird	Outperform → Neutral
Feb-03-21	Downgrade	BTIG Research	Buy → Neutral
Feb-03-21	Downgrade	Wedbush	Outperform → Neutral
Dec-24-20	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Dec-23-20	Downgrade	Raymond James	Outperform → Mkt Perform
Nov-11-20	Downgrade	Oppenheimer	Outperform → Perform
Nov-10-20	Downgrade	Raymond James	Strong Buy → Outperform
Nov-10-20	Downgrade	Wells Fargo	Overweight → Equal Weight
Mar-19-20	Initiated	The Benchmark Company	Buy
Feb-06-20	Initiated	Oppenheimer	Outperform
Nov-15-18	Upgrade	Raymond James	Outperform → Strong Buy
Sep-10-18	Resumed	BTIG Research	Buy
Sep-10-18	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-04-18	Initiated	H.C. Wainwright	Buy
Mar-12-18	Downgrade	Evercore ISI	Outperform → In-line
Mar-12-18	Downgrade	Wedbush	Outperform → Neutral
Feb-02-18	Initiated	Morgan Stanley	Overweight
Nov-28-17	Resumed	Piper Jaffray	Overweight
Oct-31-17	Initiated	Robert W. Baird	Outperform
Oct-27-17	Initiated	Canaccord Genuity	Buy
Oct-23-17	Reiterated	Stifel	Buy
Oct-12-17	Initiated	Raymond James	Outperform
Aug-17-17	Initiated	Evercore ISI	Outperform
Jul-28-17	Resumed	Stifel	Buy

View All

Voyager Therapeutics Inc Stock (VYGR) Latest News

07:43 AM

VYGRVoyager Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

07:43 AM

07:07 AM

Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast - StockTitan

07:07 AM

04:14 AM

Learn to Evaluate (VYGR) using the Charts - Stock Traders Daily

04:14 AM

Nov 02, 2024

Voyager Therapeutics (NASDAQ:VYGR) Rating Increased to Buy at StockNews.com - MarketBeat

Nov 02, 2024

Oct 28, 2024

Voyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Canada Finance

Oct 28, 2024

Brokerages Set Voyager Therapeutics, Inc. (NASDAQ:VYGR) PT at $17.43 - MarketBeat

Oct 28, 2024

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Rating of “Buy” from Analysts - Defense World

Oct 28, 2024

Oct 27, 2024

Voyager Therapeutics (NASDAQ:VYGR) Earns Buy Rating from HC Wainwright - Defense World

Oct 27, 2024

Voyager Therapeutics (NASDAQ:VYGR) Stock Rating Lowered by StockNews.com - Defense World

Oct 27, 2024

Oct 26, 2024

StockNews.com Lowers Voyager Therapeutics (NASDAQ:VYGR) to Hold - MarketBeat

Oct 26, 2024

Oct 25, 2024

How to Take Advantage of moves in (VYGR) - Stock Traders Daily

Oct 25, 2024

Oct 24, 2024

HC Wainwright Reaffirms Buy Rating for Voyager Therapeutics (NASDAQ:VYGR) - MarketBeat

Oct 24, 2024

Oct 18, 2024

Equities Analysts Offer Predictions for VYGR Q3 Earnings - MarketBeat

Oct 18, 2024

Voyager Therapeutics (NASDAQ:VYGR) Rating Increased to Strong-Buy at Leerink Partnrs - Defense World

Oct 18, 2024

Oct 17, 2024

Voyager Therapeutics (NASDAQ:VYGR) Upgraded at Leerink Partnrs - MarketBeat

Oct 17, 2024

Improved Revenues Required Before Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock's 27% Jump Looks Justified - Simply Wall St

Oct 17, 2024

Oct 16, 2024

Leerink Partners Begins Coverage on Voyager Therapeutics (NASDAQ:VYGR) - MarketBeat

Oct 16, 2024

In-Depth Examination Of 4 Analyst Recommendations For Voyager Therapeutics - Benzinga

Oct 16, 2024

Oct 15, 2024

The Manufacturers Life Insurance Company Increases Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Oct 15, 2024

Gene Therapy in CNS Disorder Market Rapid Growth at Deep Value Price :Voyager Therapeutics, Spark Therapeutics, Novartis – IndiaPolitics.com - IndiaPolitics.com

Oct 15, 2024

Oct 14, 2024

(VYGR) Technical Pivots with Risk Controls - Stock Traders Daily

Oct 14, 2024

Tau Inhibitors Clinical Trial Pipeline Analysis Demonstrates 25+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire Inc.

Oct 14, 2024

Investing in Voyager Therapeutics (NASDAQ:VYGR) three years ago would have delivered you a 58% gain - Yahoo Finance

Oct 14, 2024

Oct 13, 2024

Intracranial Therapeutic Market Rewriting its Growth Cycle |Novartis AG, BioMarin, CORESTEM Inc., Alaunos Therapeutics, – IndiaPolitics.com - IndiaPolitics.com

Oct 13, 2024

Oct 12, 2024

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Short Interest Update - MarketBeat

Oct 12, 2024

Oct 10, 2024